NCT02265627 Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Patients With Hepatic Impairment in Comparison to Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02265302 Safety, Tolerability, Biological Effects and Pharmacokinetics of BIIL 284 BS in Healthy Males Status COMPLETED Phase PHASE1
NCT02265289 Influence of Clopidogrel on the Pharmacodynamics and Safety of Fradafiban in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02264197 Investigation of Pharmacokinetics of BIBX 245 CL and Safety in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02264184 Study to Investigate the Effect of Paroxetine Mediated CYP2D6 Inhibition on the Pharmacokinetics of Tamsulosin in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02264171 Study to Investigate the Effect of Ketoconazole Mediated CYP3A4 Inhibition on Pharmacokinetics of Tamsulosin in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02264158 Influence of Telmisartan and Lacidipine, Combined or Alone, on QT Interval in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02264145 The Effect of Alcoholic-carrier Solutions Within Devices (HFA134a-MDI or Respimat®) on Breath Alcohol Measured by Ethylometer in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02264132 Increasing Dose Study of Pramipexole in Two-way Cross-over Comparison of ER Tablet Versus IR Tablet in Japanese Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02264119 Influence of Pantoprazole on the Pharmacokinetics of Fradafiban After Multiple Oral Doses of Lefradafiban in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02264106 Influence of Pantoprazole on the Pharmacokinetics of Fradafiban After Multiple Oral Doses of Lefradafiban Over 5 Days in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02264093 Effects on the Airway Lumen of Talsaclidine in Combination With Propranolol in Comparison to the Effects of the Monosubstances in Healthy Elderly Male Volunteers Status COMPLETED Phase PHASE1
NCT02264080 Pharmacokinetics and Safety of WAL2014 (Talsaclidine) Administered Orally to Healthy Adult Male Volunteers Status COMPLETED Phase PHASE1
NCT02264067 Pharmacokinetics and Safety of WAL2014 (Talsaclidine) in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02264054 Pharmacokinetics of Talsaclidine After Administration to Healthy Subjects Status COMPLETED Phase PHASE1
NCT02264041 Effect of Cytochrome P 450 3A4 Inhibition by Itraconazole on the Single Oral Dose Pharmacokinetics of Cilobradine Status COMPLETED Phase PHASE1
NCT02264028 Metabolism and Pharmacokinetics of [14C]-DK-AH 269 CL in 12 Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02264015 Pharmacodynamic Effects, Safety and Tolerability of Cilobradine, to Healthy Male and Female Volunteers, With an Intra-individual Comparison to Moxifloxacin in a Subset of Volunteers Status COMPLETED Phase PHASE1
NCT02264002 Pharmacodynamic Effects, Safety and Tolerability of Cilobradine, Compared to Metoprolol Succinate and Placebo in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02263989 Bioequivalence of Telmisartan Film-coated Tablet Compared With the Conventional Telmisartan Tablet Following Oral Administration in Healthy Male Volunteers Status COMPLETED Phase PHASE1